137 related articles for article (PubMed ID: 31464957)
1. Challenges of transarterial therapy for hepatocellular carcinoma in patients with chronic kidney disease.
Lin WC; Chang CW; Chang CW; Wang TE; Chen MJ; Wang HY
Medicine (Baltimore); 2019 Aug; 98(35):e17007. PubMed ID: 31464957
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in patients with chronic kidney disease.
Lee CH; Hsieh SY; Lin JL; Liu MS; Yen TH
World J Gastroenterol; 2013 Apr; 19(16):2466-72. PubMed ID: 23674847
[TBL] [Abstract][Full Text] [Related]
3. Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Lee YH; Hsu CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Huo TI; Lee SD
J Gastroenterol Hepatol; 2012 Oct; 27(10):1581-8. PubMed ID: 22497632
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency.
Hsu CY; Huang YH; Su CW; Chiang JH; Lin HC; Lee PC; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2010 Sep; 44(8):e171-7. PubMed ID: 20048685
[TBL] [Abstract][Full Text] [Related]
5. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
6. Benefits and problems of transarterial therapy in patients with hepatocellular carcinoma and chronic kidney disease.
Watanabe M; Shibuya A; Minamino T; Murano J; Matsunaga K; Fujii K; Ogasawara G; Irie T; Woodhams R; Koizumi W
J Vasc Interv Radiol; 2014 Dec; 25(12):1947-55; quiz 1955. PubMed ID: 25306225
[TBL] [Abstract][Full Text] [Related]
7. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
[TBL] [Abstract][Full Text] [Related]
8. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.
Goel A; Mehta N; Guy J; Fidelman N; Yao F; Roberts J; Terrault N
Liver Transpl; 2014 Oct; 20(10):1221-8. PubMed ID: 25045002
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a single center experience including 221 patients.
Zeeneldin AA; Salem SE; Tabashy RH; Ibrahim AA; Alieldin NH
J Egypt Natl Canc Inst; 2013 Sep; 25(3):143-50. PubMed ID: 23932751
[TBL] [Abstract][Full Text] [Related]
10. Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
Wang J; Li X; Wang F; Shi D; Zhang J
J Cancer Res Ther; 2021 Jul; 17(3):619-624. PubMed ID: 34269290
[TBL] [Abstract][Full Text] [Related]
11. Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies.
Chen BB; Shih IL; Wu CH; Hsu C; Chen CH; Shih TT; Liu KL; Liang PC
J Vasc Interv Radiol; 2014 Mar; 25(3):371-8. PubMed ID: 24468045
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
[TBL] [Abstract][Full Text] [Related]
13. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
[TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.
Hao JF; Zhang LW; Bai JX; Li YJ; Liu JN; Zhang XL; Han JM; Li X; Jiang H; Cao N
Indian J Cancer; 2015 Feb; 51 Suppl 2():e3-8. PubMed ID: 25712839
[TBL] [Abstract][Full Text] [Related]
15. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
16. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
J Gastroenterol Hepatol; 2015 Jul; 30(7):1167-74. PubMed ID: 25675849
[TBL] [Abstract][Full Text] [Related]
17. Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.
Liu D; Liu M; Su L; Wang Y; Zhang X; Long H; Kuang M; Xie X; Lin M
J Vasc Interv Radiol; 2019 Dec; 30(12):1879-1886. PubMed ID: 31669087
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
19. Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.
Toro A; Ardiri A; Mannino M; Arcerito MC; Mannino G; Palermo F; Bertino G; Di Carlo I
BMC Surg; 2014 Jul; 14():40. PubMed ID: 24993566
[TBL] [Abstract][Full Text] [Related]
20. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.
Chen J; Lai L; Lin Q; Huang W; Cai M; Zhu K; Huang M
Oncotarget; 2017 Jan; 8(1):408-417. PubMed ID: 27880724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
